Tweet
ARMENIA HOSTS ROUNDTABLE ON PHARMACEUTICAL INDUSTRY CHALLENGES
PanARMENIAN.Net
March 16, 2012 - 12:34 AMT
PanARMENIAN.Net - From March 10-11, 2012, the Medicine Producers
and Importers Union of Armenia (MPI Union) in cooperation with the
USAID-funded Enterprise Development and Market Competitiveness project
(EDMC) organized the third "Meeting without Ties" forum in Arthur's
Resort in Aghveran, Armenia.
Various stakeholders of Armenia's pharmaceutical industry, including
local producers, drug safety specialists, representatives of foreign
pharmaceutical companies, importing companies, as well as state
officials, experts and scientists attended the meeting.
Discussion of current issues and development challenges of the
pharmaceutical industry was in was in focus of the roundtable.
Presentations were made on Armenia's adoption of EU Good Manufacturing
Practice (GMP) and Good Distribution Practice (GDP) standards by
January 1, 2013 in accordance with the Government of Armenia decision.
The new draft law on Pharmaceuticals and Bioactive Additives, latest
amendments to drug advertisement permissions as well as issues related
to tax and customs reforms were discussed. The USAID/EDMC project
presented its activity and upcoming plans in pharmaceutical industry.
During the forum the participants had the opportunity to meet
with government officials and discuss issues of concern related to
competitiveness in the sector.
The five-year EDMC is designed to raise incomes and employment in
Armenia by promoting growth in selected value chains with export
potential, with the overall goal of assisting Armenia to develop a
more competitive and diversified private sector.
From: Emil Lazarian | Ararat NewsPress
PanARMENIAN.Net
March 16, 2012 - 12:34 AMT
PanARMENIAN.Net - From March 10-11, 2012, the Medicine Producers
and Importers Union of Armenia (MPI Union) in cooperation with the
USAID-funded Enterprise Development and Market Competitiveness project
(EDMC) organized the third "Meeting without Ties" forum in Arthur's
Resort in Aghveran, Armenia.
Various stakeholders of Armenia's pharmaceutical industry, including
local producers, drug safety specialists, representatives of foreign
pharmaceutical companies, importing companies, as well as state
officials, experts and scientists attended the meeting.
Discussion of current issues and development challenges of the
pharmaceutical industry was in was in focus of the roundtable.
Presentations were made on Armenia's adoption of EU Good Manufacturing
Practice (GMP) and Good Distribution Practice (GDP) standards by
January 1, 2013 in accordance with the Government of Armenia decision.
The new draft law on Pharmaceuticals and Bioactive Additives, latest
amendments to drug advertisement permissions as well as issues related
to tax and customs reforms were discussed. The USAID/EDMC project
presented its activity and upcoming plans in pharmaceutical industry.
During the forum the participants had the opportunity to meet
with government officials and discuss issues of concern related to
competitiveness in the sector.
The five-year EDMC is designed to raise incomes and employment in
Armenia by promoting growth in selected value chains with export
potential, with the overall goal of assisting Armenia to develop a
more competitive and diversified private sector.
From: Emil Lazarian | Ararat NewsPress